BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers
Huong Meeks(University of Utah), Pascal Guénel(Inserm), Marjanka K. Schmidt(University of Cambridge), Frederik Marmé(Heidelberg University), Matthias W. Beckman(Universitätsklinikum Erlangen), Elizabeth J. van Rensburg(University of Pretoria), Paul A. James(The Royal Melbourne Hospital), Peter A. Fasching(Universitätsklinikum Erlangen), Honglin Song(University of Cambridge), Bing Feng(University of Utah), Annegien Broeks, Joe Dennis(University of Cambridge), Andrew K. Godwin(The University of Melbourne), Andrea Tesoriero(The University of Melbourne), Ian Campbell(The University of Sydney), Ian Tomlinson(University of Oxford), Daniel Barrowdale(University of Cambridge), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Nadine Tung(Beth Israel Deaconess Medical Center), Kathryn L. Terry(Brigham and Women's Hospital), Shelley S. Tworoger(Oregon Health & Science University), Ramūnas Janavičius(Vilnius University), Daniel W. Cramer(Brigham and Women's Hospital), Elinor J. Sawyer(King's College London), Susana Banerjee(Royal Marsden NHS Foundation Trust), Elio Ríboli(Imperial College London), Olivia Fletcher(Breast Cancer Care), Ute Hamann(German Cancer Research Center), Elizabeth M. Poole(St. Elizabeth's Hospital), Saundra S. Buys(University of Utah), Usha Menon(University of South Florida), Melissa C. Southey(The University of Melbourne), Qin Wang(University of Cambridge), Cecilia M. Dorfling(QIMR Berghofer Medical Research Institute), Barbara Burwinkel(German Cancer Research Center), Fiona Bruinsma(The Netherlands Cancer Institute), Frans B.L. Hogervorst(The Netherlands Cancer Institute), Lesley McGuffog(University of Cambridge), John L. Hopper(The University of Melbourne), Laima Tihomirova(QIMR Berghofer Medical Research Institute), Anja Rudolph(QIMR Berghofer Medical Research Institute), Manjeet K. Bolla(University of Cambridge), Debra Frost(University of Cambridge), Steve Ellis(University of Utah), HEBON(Breast Cancer Research Foundation), kConFab Investigators(Cancer Council Victoria), Australia Ovarian Cancer Study Group(The Netherlands Cancer Institute), Judy E. Garber(Dana-Farber Cancer Institute), EMBRACE(University of Cambridge), Nichola Johnson(Institute of Cancer Research)
Cited by 92
Related Papers
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
|Choice Reviews Online|2008|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k